6533b854fe1ef96bd12af9d9

RESEARCH PRODUCT

Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).

Silvio TripiAmedea Caterina AlessandriOnofrio VuturoMaurizio SoresiGiuseppe MontaltoDi Gaetano GSpadaro AFreni MBruno SSiciliano R

subject

http://hdl.handle.net/10447/18848